Literature DB >> 28275622

"You don't need a weather man to know which way the wind blows": understanding differences and applications in clinical practice of randomized controlled trials on unprotected left main.

Fabrizio D'Ascenzo1, Ovidio De Filippo1, Maurizio Bertaina1, Mario Iannaccone1, Fiorenzo Gaita1.   

Abstract

Entities:  

Year:  2017        PMID： 28275622      PMCID： PMC5337203          DOI： 10.21037/atm.2017.01.72

Source DB:  PubMed          Journal:  Ann Transl Med        ISSN： 2305-5839


× No keyword cloud information.
  11 in total

1.  Long-term safety and efficacy of stenting versus coronary artery bypass grafting for unprotected left main coronary artery disease: 5-year results from the MAIN-COMPARE (Revascularization for Unprotected Left Main Coronary Artery Stenosis: Comparison of Percutaneous Coronary Angioplasty Versus Surgical Revascularization) registry.

Authors:  Duk-Woo Park; Ki Bae Seung; Young-Hak Kim; Jong-Young Lee; Won-Jang Kim; Soo-Jin Kang; Seung-Whan Lee; Cheol Whan Lee; Seong-Wook Park; Sung-Cheol Yun; Hyeon-Cheol Gwon; Myung-Ho Jeong; Yang-Soo Jang; Hyo-Soo Kim; Pum Joon Kim; In-Whan Seong; Hun Sik Park; Taehoon Ahn; In-Ho Chae; Seung-Jea Tahk; Wook-Sung Chung; Seung-Jung Park
Journal:  J Am Coll Cardiol       Date:  2010-05-06       Impact factor: 24.094

2.  Comparison of Percutaneous Coronary Intervention With Coronary Artery Bypass Grafting in Unprotected Left Main Coronary Artery Disease - 5-Year Outcome From CREDO-Kyoto PCI/CABG Registry Cohort-2 - .

Authors:  Hiroki Shiomi; Takeshi Morimoto; Yutaka Furukawa; Yoshihisa Nakagawa; Ryuzo Sakata; Hitoshi Okabayashi; Michiya Hanyu; Mitsuomi Shimamoto; Noboru Nishiwaki; Tatsuhiko Komiya; Takeshi Kimura
Journal:  Circ J       Date:  2015-03-30       Impact factor: 2.993

Review 3.  Prevalence and non-invasive predictors of left main or three-vessel coronary disease: evidence from a collaborative international meta-analysis including 22 740 patients.

Authors:  Fabrizio D'Ascenzo; Davide Giacomo Presutti; Elisa Picardi; Claudio Moretti; Pierluigi Omedè; Filippo Sciuto; Marco Novara; Andrew T Yan; Shaun Goodman; Nitin Mahajan; Masami Kosuge; Alberto Palazzuoli; Gwo-Ping Jong; Hussain Isma'eel; Matthew J Budoff; Ronen Rubinshtein; Henry Gewirtz; Matthew J Reed; Pierre Theroux; Giuseppe Biondi-Zoccai; Maria Grazia Modena; Imad Sheiban; Fiorenzo Gaita
Journal:  Heart       Date:  2012-06       Impact factor: 5.994

4.  Everolimus-Eluting Stents or Bypass Surgery for Left Main Coronary Artery Disease.

Authors:  Gregg W Stone; Joseph F Sabik; Patrick W Serruys; Charles A Simonton; Philippe Généreux; John Puskas; David E Kandzari; Marie-Claude Morice; Nicholas Lembo; W Morris Brown; David P Taggart; Adrian Banning; Béla Merkely; Ferenc Horkay; Piet W Boonstra; Ad J van Boven; Imre Ungi; Gabor Bogáts; Samer Mansour; Nicolas Noiseux; Manel Sabaté; José Pomar; Mark Hickey; Anthony Gershlick; Pawel Buszman; Andrzej Bochenek; Erick Schampaert; Pierre Pagé; Ovidiu Dressler; Ioanna Kosmidou; Roxana Mehran; Stuart J Pocock; A Pieter Kappetein
Journal:  N Engl J Med       Date:  2016-10-31       Impact factor: 91.245

5.  Main left coronary artery disease. Clinical experience from 1964-1974.

Authors:  M V Cohen; R Gorlin
Journal:  Circulation       Date:  1975-08       Impact factor: 29.690

6.  5-year outcomes following percutaneous coronary intervention with drug-eluting stent implantation versus coronary artery bypass graft for unprotected left main coronary artery lesions the Milan experience.

Authors:  Alaide Chieffo; Valeria Magni; Azeem Latib; Francesco Maisano; Alfonso Ielasi; Matteo Montorfano; Mauro Carlino; Cosmo Godino; Massimo Ferraro; Giliola Calori; Ottavio Alfieri; Antonio Colombo
Journal:  JACC Cardiovasc Interv       Date:  2010-06       Impact factor: 11.195

7.  Provisional vs. two-stent technique for unprotected left main coronary artery disease after ten years follow up: A propensity matched analysis.

Authors:  Fabrizio D'Ascenzo; Mario Iannaccone; Francesca Giordana; Alaide Chieffo; Stephen O Connor; L Christian Napp; SujaySubash Chandran; José María de la Torre Hernández; Shao-Liang Chen; Ferdinando Varbella; Pierluigi Omedè; Salma Taha; Emanuele Meliga; Hiroyoshi Kawamoto; Antonio Montefusco; Mervyn Chong; Philippe Garot; Lin Sin; Valeria Gasparetto; Mohamed Abdirashid; Enrico Cerrato; Giuseppe Biondi-Zoccai; Fiorenzo Gaita; Javier Escaned; David Hiddick Smith; Thierry Lefèvre; Antonio Colombo; Imad Sheiban; Claudio Moretti
Journal:  Int J Cardiol       Date:  2016-03-03       Impact factor: 4.164

8.  Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease.

Authors:  Patrick W Serruys; Marie-Claude Morice; A Pieter Kappetein; Antonio Colombo; David R Holmes; Michael J Mack; Elisabeth Ståhle; Ted E Feldman; Marcel van den Brand; Eric J Bass; Nic Van Dyck; Katrin Leadley; Keith D Dawkins; Friedrich W Mohr
Journal:  N Engl J Med       Date:  2009-02-18       Impact factor: 91.245

9.  Five-year outcomes in patients with left main disease treated with either percutaneous coronary intervention or coronary artery bypass grafting in the synergy between percutaneous coronary intervention with taxus and cardiac surgery trial.

Authors:  Marie-Claude Morice; Patrick W Serruys; A Pieter Kappetein; Ted E Feldman; Elisabeth Ståhle; Antonio Colombo; Michael J Mack; David R Holmes; James W Choi; Witold Ruzyllo; Grzegorz Religa; Jian Huang; Kristine Roy; Keith D Dawkins; Friedrich Mohr
Journal:  Circulation       Date:  2014-04-03       Impact factor: 29.690

10.  Long-Term (≥10 Years) Safety of Percutaneous Treatment of Unprotected Left Main Stenosis With Drug-Eluting Stents.

Authors:  Imad Sheiban; Claudio Moretti; Fabrizio D'Ascenzo; Alaide Chieffo; Salma Taha; Stephen O Connor; SujaySubash Chandran; J M de la Torre Hernández; Sl Chen; Ferdinando Varbella; Pierluigi Omedè; Mario Iannaccone; Emanuele Meliga; Hiroyoshi Kawamoto; Antonio Montefusco; Chong Mervyn; Philippe Garot; Lin Sin; Valeria Gasparetto; Mohamed Abdirashid; Enrico Cerrato; Giuseppe Biondi Zoccai; Fiorenzo Gaita; Javier Escaned; David Hiddick Smith; Thierry Lefèvre; Antonio Colombo
Journal:  Am J Cardiol       Date:  2016-04-26       Impact factor: 2.778
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.